Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05615896 · ClinicalTrials.gov registry record · NA
Data Collection With the P200TE and P200TxE
A NA study, sponsored by Optos.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05615896: Clinical Trial NA study, sponsored by Optos.
NCT05615896 is a NA study that was terminated before completion, run by Optos. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05615896, a NA study, was terminated before completion, sponsored by Optos.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The primary objective is to collect OCT scans on a modified P200TxE and P200TE.
Primary Outcome
The primary endpoint will be the collection of OCT scans on the P200TE and P200TxE devices. The scans will be used by R\&D for development of a de-noising algorithm as well as other possible developments.
Interventions
- DEVICE Imaging Session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-04-22 |
| Est. Completion | 2022-06-17 |
| Phase | NA |
Why NCT05615896 stopped before completion
NCT05615896 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Imaging Session is the first listed.
NCT05615896 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05615896 about?
NCT05615896 is a clinical study titled "Data Collection With the P200TE and P200TxE". The primary objective is to collect OCT scans on a modified P200TxE and P200TE.
What is the current status of trial NCT05615896?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2021-04-22. Estimated completion is 2022-06-17.
What interventions are being tested in trial NCT05615896?
The interventions under investigation include: Imaging Session (DEVICE).
Who is sponsoring clinical trial NCT05615896?
This trial is sponsored by Optos, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05615896's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI